PHARMAGAP INC has a total of 13 patent applications. Its first patent ever was published in 2002. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are THYMON LLC, GENEURO SA and GOLETZ STEFFEN.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Canada | 2 | |
#4 | Australia | 1 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Terreux Raphael | 10 |
#2 | Phipps Jenny | 10 |
#3 | Sokoll Kenneth | 2 |
#4 | Chabot Jaclyn Melinda | 1 |
#5 | Isaacs Richard John | 1 |
Publication | Filing date | Title |
---|---|---|
WO2013033838A1 | Liposomal formulations of cationic peptides and uses thereof | |
WO2013026157A1 | Anti-cancer peptides and uses thereof | |
EP1922328A1 | Peptides targeted to protein kinase c isoforms and uses thereof | |
EP1922086A1 | Targeted protein kinase c inhibitors and uses thereof | |
EP1877424A1 | Inhibitors of protein kinases and uses thereof | |
AU2002351603A1 | Method for culturing and expansion of mammalian undifferentiated epidermal keratinocytes exhibiting stem cell characteristics |